Clinical Trials · NCT02396966

Quality of Life (QoL) in Subjects With Acromegaly Under Lanreotide Autogel® Treatment.

Name: Quality of Life (QoL) in Subjects With Acromegaly Under Lanreotide Autogel® Treatment.
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedN/ALanreotide

Phase: N/A
Recruitment status: Completed
Sponsor: Ipsen
Enrollment: 152
Start date: Dec 2014
Locations: 18 sites, Poland
Primary endpoint: Acromegaly quality of life (AcroQol) questionnaire

View Lanreotide compound reference